We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots

By HospiMedica International staff writers
Posted on 29 Oct 2026

Pulmonary embolism occurs when blood clots travel to the lungs and block blood flow, potentially requiring urgent endovascular intervention to prevent death. More...

Catheter-based clot removal can be challenging, as clinicians must navigate fragile vessels and heart valves before reaching large clot burdens. To support clot removal in this difficult anatomy, researchers have developed a thrombectomy system that combines suction with controlled agitation.

Researchers at the University of Michigan (Ann Arbor, MI, USA) developed the Hēlo Thrombectomy System through collaboration between engineering and clinical teams. The device was recently cleared by the U.S. Food and Drug Administration (FDA) for patients with chronic venous thromboembolism involving lung clots. Commercialization is being led by Endovascular Engineering, a University of Michigan startup founded in 2020.

The system is designed to enter the vasculature as a small catheter and expand into a larger funnel once it reaches the clot. The funnel applies suction while a rotating shaft orbits and twists the clot. This action stretches and thins the clot so it can be drawn through the catheter and removed from the body. The approach is intended to reduce reliance on direct grabbing and pulling, which the development team found could damage blood vessels.

The technology originated in work on stroke intervention and was adapted for pulmonary embolism. It was developed at the Biomedical Manufacturing and Design Lab at the University of Michigan and involved collaboration between University of Michigan Engineering, Michigan Medicine, neurosurgery, cardiology, and the University of Minnesota. Endovascular Engineering also reported positive results from the ENGULF trial, a key clinical trial evaluating the Hēlo system for pulmonary embolism treatment, which helped support FDA clearance.

The same collaboration has generated additional minimally invasive medical device efforts, including technologies for cartilage removal, heart pumping assistance, and chronic clot crossing in leg veins. The Hēlo system is presented as an early commercial application before further development of more complex stroke treatment devices.

“The FDA clearance of the Hēlo Thrombectomy System marks a transformative advancement for pulmonary embolism patients. This significant milestone demonstrates the tremendous power of interdisciplinary innovation at U-M, where engineers and clinicians come together to tackle urgent clinical challenges. We’re proud to support startups like Endovascular Engineering, driving breakthrough technologies like Hēlo from university research to patient care” said Kelly Sexton, U-M associate vice president for research—innovation partnerships and economic impact.

“It is an ideal start before the technology advancement and commercialization of more complex stroke treatment devices,” said Albert Shih, professor of mechanical engineering and biomedical engineering.

Related Links
University of Michigan
Endovascular Engineering


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Preoperative Skin Preparation
BD ChloraPrep
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Design-science framework integrating CML and LLM pipelines for supply chain risk evaluation. (Gupta I, Konduru H, Correa S, et al. A causal analytics approach for interpretable supply chain risk and supplier performance evaluation. Supply Chain Analytics, 2026. doi:10.1016/j.sca.2026.100248)

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. However, artificial intelligence (AI) systems may... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: Overview of the study design, including participant recruitment, multimodal neuroimaging analysis, stage- and cognition-informed feature selection, and development and validation of the DBFG-Net model. CKD-CI, CKD with cognitive impairment; CKD-NCI, CKD without cognitive impairment; HCs, healthy controls; CBF, cerebral blood flow; DBFG-Net, Dual-Branch Feature-Gated Network. (Photo courtesy of Wenbo Yang and Lijun Song, Capital Medical University)

AI Combines Brain Imaging Features to Identify Cognitive Impairment in CKD

Chronic kidney disease (CKD) can affect multiple organs, including the brain, with cognitive impairment emerging as a common complication. Changes in executive function, attention, and memory can reduce... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.